Last10K.com

Yubo International Biotech Ltd (YBGJ) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, June 30, 2021

Magna Lab Inc

CIK: 895464 Ticker: YBGJ
Cover - shares
6 Months Ended
Jun. 30, 2021
Aug. 19, 2021
Cover [Abstract]  
Entity Registrant NameYUBO INTERNATIONAL BIOTECH LIMITED 
Entity Central Index Key0000895464 
Document Type10-Q 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Entity Small Businesstrue 
Entity Shell Companyfalse 
Entity Emerging Growth Companyfalse 
Entity Current Reporting StatusYes 
Document Period End DateJun. 30, 2021 
Entity Filer CategoryNon-accelerated Filer 
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2021 
Entity Common Stock Shares Outstanding 118,177,885
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number0-21320 
Entity Incorporation State Country CodeNY 
Entity Tax Identification Number11-3074326 
Entity Address Address Line 1Room 105, Building 5, 31 Xishiku Avenue 
Entity Address Address Line 2Xicheng District 
Entity Address City Or TownBeijing 
Entity Address CountryCN 
Entity Address Postal Zip Code00-000 
City Area Code010 
Local Phone Number6615-5141 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate Magna Lab Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Magna Lab Inc.

Continue

Assess how Magna Lab Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Magna Lab Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows (Unaudited)
Consolidated Statements Of Changes In Stockholders' Equity (Unaudited)
Consolidated Statements Of Operations And Comprehensive Loss (Unaudited)
Advances From Prospective Customersdistributors
Advances From Prospective Customersdistributors (Details Narrative)
Commitments And Contingencies
Commitments And Contingencies (Details Narrative)
Due From Related Parties
Due From Related Parties (Details)
Due From Related Parties (Tables)
Due To Related Parties
Due To Related Parties (Details)
Due To Related Parties (Tables)
Going Concern
Going Concern (Details Narrative)
Income Tax
Income Tax (Details 1)
Income Tax (Details Narrative)
Income Tax (Details)
Income Tax (Tables)
Intangible Assets
Intangible Assets (Details 1)
Intangible Assets (Details)
Intangible Assets (Tables)
Inventory
Inventory (Details)
Inventory (Tables)
Operating Lease Right Of Use Asset And Operating Lease Liability
Operating Lease Right Of Use Asset And Operating Lease Liability (Details Narrative)
Operating Lease Right Of Use Asset And Operating Lease Liability (Details)
Operating Lease Right Of Use Asset And Operating Lease Liability (Tables)
Organization
Organization (Details Narrative)
Organization (Details)
Organization (Tables)
Property And Equipment
Property And Equipment (Details Narrative)
Property And Equipment (Details)
Property And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Details Narrative)
Shareholders Equity
Shareholders Equity (Details Narrative)
Shareholders Equity (Details)
Shareholders Equity (Tables)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details )
Summary Of Significant Accounting Policies (Details 1)
Summary Of Significant Accounting Policies (Details 2)
Summary Of Significant Accounting Policies (Details 3)
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)

Material Contracts, Statements, Certifications & more

Magna Lab Inc provided additional information to their SEC Filing as exhibits

Ticker: YBGJ
CIK: 895464
Form Type: 10-Q Quarterly Report
Accession Number: 0001640334-21-002005
Submitted to the SEC: Fri Aug 20 2021 4:07:37 PM EST
Accepted by the SEC: Fri Aug 20 2021
Period: Wednesday, June 30, 2021
Industry: Electromedical And Electrotherapeutic Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ybgj/0001640334-21-002005.htm